跳至主要内容
临床试验/SLCTR/2014/016
SLCTR/2014/016尚未招募未知

Effect of pentoxyfylline on histological activity and fibrosis of patients with nonalcoholic steatohepatitis

Bangabandhu Sheikh Mujib Medical University0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Ultrasonographic evidence of fatty liver
  • 2. Nonalcoholic fatty liver disease activity score greater than or equal to 5 on liver histopathology

排除标准

  • 1. Significant alcohol intake(more than 20 gm /day)
  • 2. History of taking drugs that may cause fatty liver(i.e.tamoxifen, valproic acid, amiodarone, methotrexate) or history of taking drugs that have shown benefit in previous Nonalcoholic steatohepatitis studies(i.e.vitamin E ,metformin, thiazolidinedione, fibrates)
  • 3. Chronic viral hepatitis(HBV , HCV)
  • 4. Pregnancy
  • 5. Co-morbid conditions(Chronic Obstructive Pulmonary Disease ,Chronic Kidney Disease, Congestive CF, Myocardial infarction)
  • 6. Liver failure
  • 7. Hypothyroidism
  • 8. Patient who fails to give consent for paired biopsy
  • 9. Wilson's disease and Hemochromatosis

研究者

相似试验

Effectiveness of pentoxyfylline in patients with... | 临床试验